Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China · Delayed Price · Currency is CNY 99.49
-3.21 (-3.13%)
Sep 11, 2026, 3:00 PM CST
SHA:688578 Market Cap
SHA:688578 has a market cap or net worth of 44.77 billion as of September 11, 2026. Its market cap has decreased by -12.47% in one year.
Market Cap
44.77B
Enterprise Value
40.53B
Revenue
6.13B
Ranking
n/a
PE Ratio
16.75
Stock Price
99.49
ChartMarket Cap Chart
Since December 2, 2020, SHA:688578's market cap has increased from 17.35B to 44.77B, an increase of 158.08%. That is a compound annual growth rate of 17.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 44.77B | -4.47% |
| Dec 31, 2025 | 46.87B | 73.87% |
| Dec 31, 2024 | 26.96B | 43.78% |
| Dec 29, 2023 | 18.75B | 111.69% |
| Dec 30, 2022 | 8.86B | -34.83% |
| Dec 31, 2021 | 13.59B | 6.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmaron Beijing | 70.05B |
| Haisco Pharmaceutical Group | 69.99B |
| Asymchem Laboratories (Tianjin) | 59.81B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 36.21B |
| Beijing Wantai Biological Pharmacy Enterprise | 35.48B |
| Shanghai RAAS Blood Products | 32.90B |
| Chongqing Zhifei Biological Products | 30.54B |
| Suzhou Zelgen Biopharmaceuticals | 28.76B |